Literature DB >> 7512745

CD44 splice variants; expression on lymphocytes and in neoplasia.

G Koopman1, A W Griffioen, H Ponta, P Herrlich, F van den Berg, E Manten-Horst, S T Pals.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7512745     DOI： 10.1016/s0923-2494(93)80061-3

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  6 in total

Review 1.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

2.  Trans-acting factors regulate the expression of CD44 splice variants.

Authors:  H Konig; J Moll; H Ponta; P Herrlich
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

3.  Expression of CD44 splice variants in human primary brain tumors.

Authors:  P Kaaijk; D Troost; F Morsink; R M Keehnen; S Leenstra; D A Bosch; S T Pals
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

Review 4.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

5.  Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.

Authors:  G Sliutz; C Tempfer; S Winkler; P Kohlberger; A Reinthaller; C Kainz
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

Review 6.  Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.

Authors:  Hongxia Wang; Nikolas H Stoecklein; Peter P Lin; Olivier Gires
Journal:  Oncotarget       Date:  2017-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.